Novavax to Report First-Quarter Earnings: Is a Beat in Store?

We expect Novavax (NVAX) to surpass expectations when it reports first-quarter 2025 earnings on May 8, before the opening bell. The company’s earnings beat estimates by 32% in the last reported quarter.The Zacks Consensus Estimate for sales is pegged at $71.84 million, while that for earnings is pinned at 19 cents per share. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar)Factors Shaping NVAX’s Upcoming ResultsStarting this year, pharma giant Sanofi (SNY) acquired exclusive rights to ...